MedTrace Logo

A Neurocognitive and Immunological Study of a New Formula for Healthy Infants

NCT02094547 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2019-07-12

No results posted yet for this study

Summary

To compare the neurocognitive and immunological development in infants fed a new infant formula with functional specific nutrients to infants consuming a standard infant formula.

Conditions

  • Infant Development

Interventions

DIETARY_SUPPLEMENT

New infant formula

New infant formula

DIETARY_SUPPLEMENT

Standard infant formula

Standard infant formula

DIETARY_SUPPLEMENT

Breastfeeding

Exclusive breastfeeding or less tan 25% formula intake

Sponsors & Collaborators

  • Laboratorios Ordesa

    lead INDUSTRY

Principal Investigators

  • Cristina Campoy, Professor · Universidad de Granada

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
60 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2016-03-31
Completion
2020-10-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094547 on ClinicalTrials.gov